Newsroom

Sorted by: Latest

-

Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership

PALO ALTO, Calif. & HONG KONG--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of the Shield™ multi-cancer detection (MCD) laboratory developed test (LDT) in multiple markets in Asia. The Shield MCD test is a methylation-based blood test for the detection of multiple cancer types including bladder, colorectal, breast, prostate, esophageal, gastric, liver, lung, ovarian and pancreas cancer in individuals aged 45 or older who a...
-

Ameresco Completes District-Wide Energy Efficiency Transformation for Charlo School District

FRAMINGHAM, Mass. & CHARLO, Mont.--(BUSINESS WIRE)--Ameresco, Inc., (NYSE: AMRC), a leading energy infrastructure solutions provider, today announced it has completed a comprehensive Energy Performance Contract (EPC) for Charlo School District in Charlo, Montana. Designed to create a more optimized learning environment, the project targeted modernizing aging infrastructure, improving indoor comfort, and reducing long-term energy and maintenance costs. Conducted in two phases, the project delive...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NYSE Arca Biotechnology UCITS ETF 13.03.2026 FBTU.LN IE00BL0L0H60 500,002.00 USD 11,803,294.53 23.606  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Capital Strength UCITS ETF 13.03.2026 FTCS. IE00BL0L0D23 275,002.00 USD 9,001,586.55 32.733  ...
-

HyperLight Demonstrates Low-Power 1.6T-DR8 TFLN-based Reference Transceiver Assembled by TFC

CAMBRIDGE, Mass.--(BUSINESS WIRE)--HyperLight Corporation (“HyperLight”) today announced a major milestone in low-power optical networking with the demonstration of a 1.6T-DR8 optical transceiver leveraging HyperLight’s TFLN Chiplet™ Platform. The reference module was demonstrated with engineering and manufacturing support from Suzhou TFC Optical Communication Co., Ltd. (SZSE: 300394, or "TFC"). The reference design achieves 20W power consumption in a fully retimed 1.6T-DR8 module, representing...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 13.03.2026 FGOV LN IE00BKS2X200 58,638.00 GBP 868,081.65 17.125  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 13.03.2026 FVD. IE00BKVKW020 250,002.00 USD 7,254,826.43 29.019  ...
-

Semtech Launches 224Gbps IC Family for Linear Optics Era

CAMARILLO, Calif.--(BUSINESS WIRE)--Semtech Corporation (Nasdaq: SMTC), a leading provider of high-performance semiconductor, Internet of Things (IoT) systems and cloud connectivity service solutions, today announced a family of 224Gbps per lane Transimpedance Amplifiers (TIAs) and Mach-Zehnder Modulator (MZM) drivers for half retimed (LRO), LPO, XPO, Near-Packaged Optics (NPO) and Co-Packaged Optics (CPO) interconnect applications. The new CEI-224G-Linear and LPO-MSA compliant devices enable 8...
-

Okta Announces New Blueprint for the Secure Agentic Enterprise

SAN FRANCISCO--(BUSINESS WIRE)--Okta, Inc. (NASDAQ: OKTA), the leading independent identity partner, today announced a new blueprint for the secure agentic enterprise to help every organization answer three critical questions for the agentic era: where are my agents, what can they connect to, and what can they do? To help customers implement this framework, Okta is delivering Okta for AI Agents, a comprehensive platform to discover and register known and unknown AI agents, standardize agent acc...
-

Korsana Biosciences Appoints Mark Vignola, Ph.D., as Chief Financial Officer

WALTHAM, Mass.--(BUSINESS WIRE)--Korsana Biosciences, Inc. (“Korsana” or the “Company”), a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced that Mark Vignola, Ph.D., has joined as Chief Financial Officer (CFO). Dr. Vignola brings extensive leadership experience in corporate finance across the biotech industry. “We are excited to welcome Mark as our Chief Financial Officer, with his extensive experience as a stra...